Zevenbergen Capital Investments’s Cardlytics CDLX Stock Holding History

Zevenbergen Capital Investments’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,560	Closed	-$348K	–	102
2022 Q2	$348K	Hold	1,560	–	–	0.02%	81
2022 Q1	$858K	Hold	1,560	–	–	0.02%	76
2021 Q4	$1.03M	Hold	1,560	–	–	0.02%	80
2021 Q3	$1.31M	Buy	1,560 +140	+10%	+$142K	0.02%	72
2021 Q2	$1.8M	Sell	1,420 -8	-0.6%	-$9.03K	0.03%	70
2021 Q1	$1.57M	Buy	1,428 +223	+19%	+$294K	0.03%	70
2020 Q4	$1.72M	Buy	1,205 +455	+61%	+$485K	0.03%	59
2020 Q3	$529K	Buy	750 +315	+72%	+$229K	0.01%	78
2020 Q2	$304K	Buy	+435	New	+$251K	0.01%	79

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

JCM

JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zevenbergen Capital Investments's CDLX Position: Q3 2022 in Review

Zevenbergen Capital Investments sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 1,560 shares — an estimated $348K sold.

Zevenbergen Capital Investments first reported a position in CDLX in Q2 2020 and held it in 9 quarters. The position peaked at $1.8M in Q2 2021. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

Zevenbergen Capital Investments reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
Zevenbergen Capital Investments sold 1,560 Cardlytics shares in Q3 2022, an estimated $348K.
Zevenbergen Capital Investments first reported a position in Cardlytics in Q2 2020 and held it in 9 quarters.
Zevenbergen Capital Investments's Cardlytics position peaked at $1.8M in Q2 2021.
132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Zevenbergen Capital Investments's 13F filing for Q3 2022, filed 14 Nov 2022.